IN158324B - - Google Patents
Info
- Publication number
- IN158324B IN158324B IN180/CAL/84A IN180CA1984A IN158324B IN 158324 B IN158324 B IN 158324B IN 180CA1984 A IN180CA1984 A IN 180CA1984A IN 158324 B IN158324 B IN 158324B
- Authority
- IN
- India
- Prior art keywords
- derivative
- crosslinked fibrin
- fibrin derivative
- extract
- steps
- Prior art date
Links
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical class CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 abstract 8
- 239000000246 fibrin derivative Substances 0.000 abstract 8
- 239000000427 antigen Substances 0.000 abstract 3
- 102000036639 antigens Human genes 0.000 abstract 3
- 108091007433 antigens Proteins 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 3
- 230000003321 amplification Effects 0.000 abstract 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract 2
- 210000000628 antibody-producing cell Anatomy 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
- 238000010367 cloning Methods 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 abstract 1
- 238000000576 coating method Methods 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
- 239000000282 fibrinogen degradation product Substances 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000007423 screening assay Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/745—Assays involving non-enzymic blood coagulation factors
- G01N2333/75—Fibrin; Fibrinogen
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Public Health (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPF849483 | 1983-03-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN158324B true IN158324B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1986-10-18 |
Family
ID=3770042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN180/CAL/84A IN158324B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1983-03-17 | 1984-03-13 |
Country Status (18)
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4722903A (en) * | 1983-11-14 | 1988-02-02 | New York Blood Center, Inc. | Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II |
| DE3400434A1 (de) * | 1984-01-09 | 1985-09-26 | Behringwerke Ag, 3550 Marburg | Bestimmung von fibrin mit fibrin-spezifischen antikoerpern |
| JPS60166698A (ja) * | 1984-02-09 | 1985-08-29 | Dai Ichi Pure Chem Co Ltd | モノクロ−ナル抗体 |
| US5357042A (en) * | 1984-04-23 | 1994-10-18 | The General Hospital Corporation | Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity |
| US4927916A (en) * | 1984-04-23 | 1990-05-22 | The General Hospital Corporation | Method of producing fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity using fibrin-specific peptides |
| FR2569276B1 (fr) * | 1984-08-14 | 1988-02-05 | Stago Diagnostica | Procede de dosage de produits de degradation du fibrinogene |
| US5116613A (en) * | 1985-01-08 | 1992-05-26 | The General Hospital Corporation | Antibody-thrombolytic agent product and method of use |
| US4775624A (en) * | 1985-02-08 | 1988-10-04 | Eli Lilly And Company | Vectors and compounds for expression of human protein C |
| FR2593518B1 (fr) * | 1985-05-02 | 1989-09-08 | Transgene Sa | Vecteurs d'expression et de secretion de l'hirudine par les levures transformees |
| US4916070A (en) * | 1986-04-14 | 1990-04-10 | The General Hospital Corporation | Fibrin-specific antibodies and method of screening for the antibodies |
| JPH0746104B2 (ja) * | 1986-09-22 | 1995-05-17 | 株式会社ヤトロン | Ｆｄｐの測定法 |
| FI89634C (fi) * | 1987-07-10 | 1993-10-25 | Yamanouchi Pharma Co Ltd | Foerfarande, anordning och kitt foer maetning av vaevnadsplasminogenaktivator-aktivitet |
| US5582862A (en) | 1988-04-04 | 1996-12-10 | General Hospital Corporation | Antibodies that bind to α2-antiplasmin crosslinked to fibrin which do not inhibit plasma α2-antiplasmin |
| US5372812A (en) * | 1988-04-04 | 1994-12-13 | The General Hospital Corporation | Composition and method for acceleration of clot lysis |
| US5120834A (en) * | 1988-06-13 | 1992-06-09 | American Biogenetic Sciences, Inc. | Fibrin-specific monoclonal antibody |
| US5453359A (en) | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
| US5206140A (en) * | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
| IE67430B1 (en) * | 1988-06-24 | 1996-04-03 | Res Corp Technologies Inc | Assay for soluble crosslinked fibrin polymers |
| US5609869A (en) * | 1988-08-19 | 1997-03-11 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
| US5811265A (en) * | 1988-08-19 | 1998-09-22 | The General Hospital Corporation | Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use |
| CA2023354C (en) * | 1989-08-17 | 2002-08-13 | Karen Ann Thomas | Method for direct chemical binding of d-dimer from a biological sample for diagnosing and monitoring thrombolytic and hypercoagulable states |
| WO1991002547A1 (en) * | 1989-08-24 | 1991-03-07 | Australian Nuclear Science & Technology Organisation | Radio-labelled antibodies for imaging |
| FR2663748B1 (fr) * | 1990-06-22 | 1992-10-09 | Oris Ind Cie | Anticorps specifiques de la liaison isopeptidique induite par les transglutaminases, antigenes constitues par des isopeptides glu-lys reconnus par lesdits anticorps, agents de diagnostic et compositions therapeutiques les contenant. |
| US5807535A (en) * | 1992-07-31 | 1998-09-15 | Australian Nuclear Science & Technology Organisation | Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
| EP0955066A3 (en) * | 1992-07-31 | 2002-08-28 | Australian Nuclear Science And Technology Organisation | Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents |
| US5487892A (en) * | 1994-02-24 | 1996-01-30 | American Biogenetic Sciences, Inc. | Method for treating thrombotic disease using a fibrin specific monoclonal antibody |
| EP0937146A2 (en) * | 1996-09-20 | 1999-08-25 | The General Hospital Corporation | Composition and method for enhancing fibrinolysis using antibodies to alpha-2-antiplasmin |
| AU2002232518A1 (en) * | 2000-11-13 | 2002-05-21 | Sigma-Aldrich Co. | Improved assay and reagents or immunological determination of analyte concentration |
| WO2002046769A2 (en) * | 2000-12-05 | 2002-06-13 | The Penn State Research Foundation | A monoclonal antibody-based diagnostic assay for gamma fibrinogen |
| AU2002318960B2 (en) | 2001-06-26 | 2008-05-15 | Agen Biomedical Limited | Humanized antibodies derived from DD-3B6/22, specific for the D-dimer fragment of fibrin |
| US7485438B2 (en) * | 2002-03-01 | 2009-02-03 | Szu-Yi Chou | Method of producing polyvalent antigens |
| US20030224476A1 (en) * | 2002-03-01 | 2003-12-04 | Szu-Yi Chou | Method of producing transglutaminase reactive compound |
| US20030219853A1 (en) * | 2002-03-01 | 2003-11-27 | Szu-Yi Chou | Method of cross-linking a compound |
| US20040001848A1 (en) * | 2002-03-01 | 2004-01-01 | Szu-Yi Chou | Method of producing disease-specific antigens |
| DE102004052082A1 (de) | 2004-10-26 | 2006-04-27 | Dade Behring Marburg Gmbh | Durchstoßbare, flexible Vorrichtung zur Abdeckung von Flüssigkeitsbehältnissen |
| US11506674B2 (en) | 2005-07-29 | 2022-11-22 | Princeton Biomeditech Corporation | Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody |
| US8940489B2 (en) | 2005-07-29 | 2015-01-27 | Hyun-Ju Doh | Monoclonal antibody against D-dimer and diagnosis agent for detecting D-dimer, crosslinked fibrin and its derivatives containing D-dimer by using the antibody |
| WO2011125875A1 (ja) * | 2010-04-01 | 2011-10-13 | 三菱化学メディエンス株式会社 | 新規モノクローナル抗体ならびにｄダイマーの免疫学的測定法 |
| EP2600151B1 (en) | 2010-07-30 | 2016-12-21 | Sysmex Corporation | Reagent and reagent kit for measurement of fdp, and measurement method |
| TWI658268B (zh) * | 2017-11-29 | 2019-05-01 | 國立清華大學 | 血液檢測方法 |
| JPWO2021200131A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * | 2020-03-30 | 2021-10-07 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4196265A (en) * | 1977-06-15 | 1980-04-01 | The Wistar Institute | Method of producing antibodies |
| EP0113075A3 (en) * | 1982-12-06 | 1985-05-02 | Fielder Gillespie Davis Limited | Field immunoassay reaction system, method of immunoassay diagnosis and probe or carrier for use therewith |
| AU2373384A (en) * | 1982-12-06 | 1984-06-14 | Fielder Gillespie Davis Ltd. | Field immunoassay reaction system |
| US4722903A (en) * | 1983-11-14 | 1988-02-02 | New York Blood Center, Inc. | Monoclonal antibodies specific to in vivo fragments derived from human fibrinogen, human fiberin I or human fibrin II |
-
1983
- 1983-03-17 AU AU25387/84A patent/AU572125B2/en not_active Expired
-
1984
- 1984-03-09 NZ NZ207459A patent/NZ207459A/en unknown
- 1984-03-13 IN IN180/CAL/84A patent/IN158324B/en unknown
- 1984-03-13 ZA ZA841878A patent/ZA841878B/xx unknown
- 1984-03-13 PH PH30386A patent/PH22957A/en unknown
- 1984-03-15 US US06/590,054 patent/US4758524A/en not_active Expired - Lifetime
- 1984-03-16 DK DK158284A patent/DK158284A/da not_active Application Discontinuation
- 1984-03-16 DE DE3486262T patent/DE3486262T3/de not_active Expired - Lifetime
- 1984-03-16 CA CA000449733A patent/CA1247022A/en not_active Expired
- 1984-03-16 IL IL71264A patent/IL71264A/xx not_active IP Right Cessation
- 1984-03-16 AT AT84102916T patent/ATE99738T1/de not_active IP Right Cessation
- 1984-03-16 ES ES530691A patent/ES530691A0/es active Granted
- 1984-03-16 EP EP84102916A patent/EP0122478B2/en not_active Expired - Lifetime
- 1984-03-16 NO NO841023A patent/NO167338C/no not_active IP Right Cessation
- 1984-03-16 PT PT78267A patent/PT78267B/pt not_active IP Right Cessation
- 1984-03-16 GR GR74126A patent/GR81951B/el unknown
- 1984-03-17 JP JP59052065A patent/JPS59183696A/ja active Granted
- 1984-03-17 KR KR1019840001389A patent/KR840008288A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ZA841878B (en) | 1984-10-31 |
| GR81951B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1984-12-12 |
| ES8507694A1 (es) | 1985-09-01 |
| EP0122478B1 (en) | 1994-01-05 |
| DE3486262D1 (de) | 1994-02-17 |
| DK158284A (da) | 1984-09-18 |
| CA1247022A (en) | 1988-12-20 |
| DE3486262T3 (de) | 2000-10-26 |
| IL71264A (en) | 1987-10-20 |
| PT78267A (en) | 1984-04-01 |
| JPS59183696A (ja) | 1984-10-18 |
| EP0122478B2 (en) | 2000-04-12 |
| ATE99738T1 (de) | 1994-01-15 |
| KR840008288A (ko) | 1984-12-14 |
| PT78267B (en) | 1986-04-21 |
| JPH0583240B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1993-11-25 |
| NO167338C (no) | 1993-12-15 |
| AU2538784A (en) | 1984-09-20 |
| DE3486262T2 (de) | 1994-06-16 |
| PH22957A (en) | 1989-02-03 |
| NO167338B (no) | 1991-07-15 |
| DK158284D0 (da) | 1984-03-16 |
| US4758524A (en) | 1988-07-19 |
| NO841023L (no) | 1984-09-18 |
| AU572125B2 (en) | 1988-05-05 |
| ES530691A0 (es) | 1985-09-01 |
| EP0122478A2 (en) | 1984-10-24 |
| NZ207459A (en) | 1987-11-27 |
| IL71264A0 (en) | 1984-06-29 |
| EP0122478A3 (en) | 1987-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN158324B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| NO166465C (no) | Fremgangsmaate for bestemmelse av sekvensen av monomerer. | |
| ATE66531T1 (de) | Verfahren zum nachweis von immunkomplexen im serum. | |
| US4379839A (en) | Method for detecting cancer | |
| EP0248534A3 (en) | Method of detecting aids virus infection | |
| AU1245188A (en) | Analyte detection in particulate-containing samples | |
| EP0585960A3 (en) | Diagnostic method for autoimmune diseases | |
| DE3667061D1 (en) | New protein isolated from blood, process for preparing said protein, antibodies against said new protein, and pharmaceutical compositions containing said protein or said antibodies | |
| CA2062820A1 (en) | Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates | |
| DE68911574T2 (de) | Reagenzsystem zur Bestimmung des Komplexes des menschlichen Plasminogenaktivator-Inhibitors und des menschlichen Gewebeplasminogenaktivators und Testsatz dafür. | |
| AU7059187A (en) | Method for the detection of pregnancy disorders | |
| CA1287801C (en) | Method for determining human collagen peptides by way of enzyme immunoassay | |
| CA1113004A (en) | Antibody against acid phosphatase isoenzymes for detection of prostatic cancer | |
| CA2264275C (en) | Monoclonal antibody specific to an anti-human fibrin monomer, method for producing the monoclonal antibody, hybridoma, and immunoassay | |
| JPS55152458A (en) | Method of eliminating immunoreaction interference in immunological measurement method | |
| EP0220702A3 (en) | Method for the preparation of monoclonal antibody derived from immunoreactive trypsin | |
| EP0248147A3 (en) | Method of determining the presence of cancer cells | |
| NO852058L (no) | Fremgangsmaate og middel for bestemmelse av atl virus antistoffer. | |
| Nishimura et al. | Appearance of abnormal catalase antigen and concurrent deletion of normal antigen in leukocytes of myelogenous leukemia | |
| US4442088A (en) | Tumor enzyme detection | |
| JPS5646465A (en) | Measuring method for man pancreas secretory inhibiter in humor | |
| JPS6488368A (en) | Method for measuring complex of urokinase and urokinase inhibitor | |
| AU573748B2 (en) | Monoclonal antibody to cancer procoagulant and immunoassay | |
| GB1514639A (en) | Test method to determine pulmonary embolism | |
| JPS5633555A (en) | Immunilogical measuring method for substance forming combined body |